目次

1. Report Overview
1.1 Introduction to Vaccine Sales Market
1.1 Vaccine Technologies
1.1.1 Live-Attenuated Vaccines
1.1.2 Inactivated Vaccines
1.1.3 Toxoid Vaccines
1.1.4 Subunit Vaccines
1.1.5 Virus-Like Particles (VLP) Vaccines
1.1.6 Bacterial Outer Membrane Vesicle (OMV) Vaccines
1.2 Platform-based Vaccines
1.2.1 DNA Vaccines
1.2.2 mRNA Vaccines
1.2.3 Viral Vector Vaccines
1.3 Vaccine Sales Market Definition
1.4 Why You Should Read This Report
1.5 What This Report Delivers
1.6 Key Questions Answered By This Analytical Report Include:
1.7 Who is This Report For?
1.8 Methodology
1.8.1 COVID-19 Impact: Recovery Scenarios
1.8.2 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQs)
1.10 Associated Visiongain Reports
1.11 About Visiongain

2 Executive Summary
2.1 COVID-19 Vaccine Tracker
2.2 Top Recipients of COVID-19 R&D Funding
2.3 North America Leading the Overall Vaccines Market
2.4 Strong Portfolio has Propelled Sanofi & Pfizer to Dominate the Worldwide Vaccines Market

3 Global Vaccine Sales Market Dynamics
3.1 COVID-19 Impact on the Vaccine Sales Market
3.2 Current Trends in the Vaccine Sales Market
3.3 Market Driving Factors
3.3.1 Rising Focus and Government Support on Immunization Programs
3.3.2 Growing Investment in Vaccine Development
3.3.3 Increasing Company Initiatives to Enhance Vaccine R&D
3.3.4 High Prevalence of Infectious Diseases
3.3.5 Technological Advancements in Vaccine Administration
3.3.6 Rapid Need of Immunization
3.3.7 Strong Supply Backed Up by Robust R&D to Drive the Market
3.4 Market Restraining Factors
3.4.1 Inadequate Reimbursement Coverage
3.4.2 High Cost of Vaccine Development
3.4.3 Long Timelines of Vaccine Manufacturing Hinder the Growth of the Vaccines Market
3.4.4 Stringent Government Regulations for Approval
3.4.5 Inadequate Access to Vaccines
3.4.6 Product Recalls
3.5 Opportunities in the Global Market
3.5.1 High Growth Prospects in Emerging Markets
3.5.2 Focus on Therapeutic Vaccines
3.5.3 Use of Adjuvants in Vaccines
3.5.4 Government Support for Future Vaccine R&D
3.6 SWOT Analysis
3.6.1 Strengths
3.6.1.1 Growing Demand from Emerging Economies
3.6.1.2 Prevention is Better Than Cure
3.6.1.3 Growing Vaccination Awareness to Boost Market Growth
3.6.2 Weaknesses
3.6.2.1 Strong Entry Barriers to Challenge Market Growth
3.6.2.2 Capital Intensive Business
3.6.3 Opportunities
3.6.3.1 Technological Advancements
3.6.3.2 Innovations in Vaccine Market
3.6.4 Threats
3.6.4.1 Maximum Market Share Captured by Few Global Vaccine Manufacturers
3.6.4.2 Productivity Gap
3.7 PEST Analysis

4 Global Vaccine Sales Market Analysis
4.1 Global Market Outlook
4.2 Global Market Size Estimation and Forecast
4.2.1 Pre-COVID-19 Market Scenario
4.2.2 Post-COVID-19 Market Scenarios (V, U, W, L Shaped Recovery Analysis

5 Global Vaccine Sales Market Analysis by Region
5.1 North America
5.2 Europe
5.3 Asia Pacific
5.4 Latin America
5.5 MEA
5.6 Regional Market Size Estimation and Forecast
5.6.1 Pre-COVID-19 Market Scenario
5.6.2 Post-COVID-19 Market Scenarios (V, U, W, L Shaped Recovery Analysis

6 Global Vaccine Sales Market Analysis by Indication
6.1 Segment Overview
6.2 Pneumococcal
6.3 Rotavirus
6.4 Influenza
6.5 Hepatitis
6.6 COVID-19
6.7 Measles
6.8 Mumps & Varicella
6.9 Typhoid
6.10 Meningococcal
6.11 DPT
6.12 Global Market Size Estimation and Forecast by Indication
6.12.1 Pre-COVID-19 Market Scenario
6.12.2 Post-COVID-19 Market Scenarios (V, U, W, L Shaped Recovery Analysis

7 Global Vaccine Sales Market Analysis by Route of Administration
7.1 Segment Overview
7.2 Intramuscular
7.3 Subcutaneous
7.4 Oral
7.5 Global Market Size Estimation and Forecast by Route of Administration
7.5.1 Pre-COVID-19 Market Scenario
7.5.2 Post-COVID-19 Market Scenarios (V, U, W, L Shaped Recovery Analysis

8 Global Vaccine Sales Market Analysis by Type
8.1 Segment Overview
8.2 Inactivated
8.3 Live Attenuated
8.4 Toxoid
8.5 Recombinant/Conjugate/Subunit
8.6 Global Market Size Estimation and Forecast by Type
8.6.1 Pre-COVID-19 Market Scenario
8.6.2 Post-COVID-19 Market Scenarios (V, U, W, L Shaped Recovery Analysis

9 Global Vaccine Sales Market Analysis by Distribution Channel
9.1 Segment Overview
9.2 Hospital & Retail Pharmacies
9.3 Government Suppliers
9.4 Global Market Size Estimation and Forecast by Distribution Channel
9.4.1 Pre-COVID-19 Market Scenario
9.4.2 Post-COVID-19 Market Scenarios (V, U, W, L Shaped Recovery Analysis

10 Global Vaccine Sales Market Analysis by Age Group
10.1 Segment Overview
10.2 Pediatrics
10.3 Adults
10.4 Global Market Size Estimation and Forecast by Age Group
10.4.1 Pre-COVID-19 Market Scenario
10.4.2 Post-COVID-19 Market Scenarios (V, U, W, L Shaped Recovery Analysis

11 North America Vaccine Sales Market
11.1 Introduction
11.2 North America Vaccine Sales Market by Country, Forecast 2022-2032
11.3 North America Vaccine Sales Market Forecast by Indication
11.4 North America Vaccine Sales Market Forecast by Route of Administration
11.5 North America Vaccine Sales Market Forecast by Type
11.6 North America Vaccine Sales Market Forecast by Distribution Channel
11.7 North America Vaccine Sales Market Forecast by Age Group
11.8 U.S. Vaccine Sales Market Forecast, 2022-2032
11.8.1 Introduction
11.8.2 U.S. Vaccine Sales Market Revenue, 2022-2032
11.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Vaccine Sales Market Forecast, 2022-2032
11.9 Canada Vaccine Sales Market Forecast, 2022-2032
11.9.1 Introduction
11.9.2 Canada Vaccine Sales Market Revenue, 2022-2032
11.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Vaccine Sales Market Forecast, 2022-2032

12 Europe Vaccine Sales Market
12.1 Introduction
12.2 Europe Vaccine Sales Market by Country, Forecast 2022-2032
12.3 Europe Vaccine Sales Market Forecast by Indication
12.4 Europe Vaccine Sales Market Forecast by Route of Administration
12.5 Europe Vaccine Sales Market Forecast by Type
12.6 Europe Vaccine Sales Market Forecast by Distribution Channel
12.7 Europe Vaccine Sales Market Forecast by Age Group
12.8 Germany Vaccine Sales Market Forecast, 2022-2032
12.8.1 Germany Well Positioned with an Established Healthcare System
12.8.2 Germany Vaccine Sales Industry Analysis
12.8.3 Germany Vaccine Sales Market Revenue, 2022-2032
12.8.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Vaccine Sales Market Forecast, 2022-2032
12.9 UK Vaccine Sales Market Forecast, 2022-2032
12.9.1 UK Vaccine Sales Industry Analysis
12.9.2 Technological Advancements to Fuel Market Growth
12.9.3 Need to Invest in Vaccines to Offer Lucrative Growth Opportunities
12.9.4 UK Vaccine Sales Market Revenue, 2022-2032
12.9.5 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Vaccine Sales Market Forecast, 2022-2032
12.10 France Vaccine Sales Market Forecast, 2022-2032
12.10.1 France Vaccine Sales Industry Analysis
12.10.2 France Vaccine Sales Market Revenue, 2022-2032
12.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Vaccine Sales Market Forecast, 2022-2032
12.11 Italy Vaccine Sales Market Forecast, 2022-2032
12.11.1 Italy Vaccine Sales Industry Analysis
12.11.2 Italy Vaccine Sales Market Revenue, 2022-2032
12.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Vaccine Sales Market Forecast, 2022-2032
12.12 Spain Vaccine Sales Market Forecast, 2022-2032
12.12.1 Spain Vaccine Sales Market Revenue, 2022-2032
12.12.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Vaccine Sales Market Forecast, 2022-2032
12.13 Russia Vaccine Sales Market Forecast, 2022-2032
12.13.1 Impact on Sputnik V Due to Russia Invasion of Ukraine
12.13.2 Russia Vaccine Sales Market Revenue, 2022-2032
12.13.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia Vaccine Sales Market Forecast, 2022-2032
12.14 Rest of Europe Vaccine Sales Market Forecast, 2022-2032
12.14.1 Rest of Europe Vaccine Sales Market Revenue, 2022-2032
12.14.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Vaccine Sales Market Forecast, 2022-2032

13 Asia Pacific Vaccine Sales Market
13.1 Introduction
13.2 Asia Pacific Vaccine Sales Market by Country, Forecast 2022-2032
13.3 Asia Pacific Vaccine Sales Market Forecast by Indication
13.4 Asia Pacific Vaccine Sales Market Forecast by Route of Administration
13.5 Asia Pacific Vaccine Sales Market Forecast by Type
13.6 Asia Pacific Vaccine Sales Market Forecast by Distribution Channel
13.7 Asia Pacific Vaccine Sales Market Forecast by Age Group
13.8 Japan Vaccine Sales Market Forecast, 2022-2032
13.8.1 Japan Vaccine Sales Industry Analysis
13.8.2 Japan Vaccine Sales Market Revenue, 2022-2032
13.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Vaccine Sales Market Forecast, 2022-2032
13.9 China Vaccine Sales Market Forecast, 2022-2032
13.9.1 China Vaccine Sales Industry Analysis
13.9.2 China Vaccine Sales Market Revenue, 2022-2032
13.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Vaccine Sales Market Forecast, 2022-2032
13.10 India Vaccine Sales Market Forecast, 2022-2032
13.10.1 India Vaccine Sales Industry Analysis
13.10.2 Indian Vaccines Industry Has a Huge Internal Market to be Serviced
13.10.3 Research and Development in India for Vaccines Innovation and Invention
13.10.4 India Vaccine Sales Market Revenue, 2022-2032
13.10.5 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Vaccine Sales Market Forecast, 2022-2032
13.11 Australia Vaccine Sales Market Forecast, 2022-2032
13.11.1 Australia Vaccine Sales Industry Analysis
13.11.2 Australia Vaccine Sales Market Revenue, 2022-2032
13.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia Vaccine Sales Market Forecast, 2022-2032
13.12 Rest of Asia Pacific Vaccine Sales Market Forecast, 2022-2032
13.12.1 Rest of Asia Pacific Vaccine Sales Market Revenue, 2022-2032
13.12.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Vaccine Sales Market Forecast, 2022-2032

14 Latin America Vaccine Sales Market
14.1 Introduction
14.2 Latin America Vaccine Sales Market by Country, Forecast 2022-2032
14.3 Latin America Vaccine Sales Market Forecast by Indication
14.4 Latin America Vaccine Sales Market Forecast by Route of Administration
14.5 Latin America Vaccine Sales Market Forecast by Type
14.6 Latin America Vaccine Sales Market Forecast by Distribution Channel
14.7 Latin America Vaccine Sales Market Forecast by Age Group
14.8 Brazil Vaccine Sales Market Forecast, 2022-2032
14.8.1 Brazil Vaccine Sales Industry Analysis
14.8.2 Public Market Accounts for 90% of Demand
14.8.3 PAHO Announced 2 Centers in Argentina and Brazil as Regional Hubs for Development of mRNA-based Vaccine Manufacturing
14.8.4 Brazil Vaccine Sales Market Revenue, 2022-2032
14.8.5 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Vaccine Sales Market Forecast, 2022-2032
14.9 Mexico Vaccine Sales Market Forecast, 2022-2032
14.9.1 Mexico Vaccine Sales Industry Analysis
14.9.2 Emerging Region Across Latin America
14.9.3 Mexico Vaccine Sales Market Revenue, 2022-2032
14.9.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Vaccine Sales Market Forecast, 2022-2032
14.10 Rest of Latin America Vaccine Sales Market Forecast, 2022-2032
14.10.1 Rest of Latin America Vaccine Sales Market Revenue, 2022-2032
14.10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Vaccine Sales Market Forecast, 2022-2032

15 Middle East and Africa Vaccine Sales Market
15.1 Introduction
15.2 Middle East and Africa Vaccine Sales Market by Country, Forecast 2022-2032
15.3 Middle East and Africa Vaccine Sales Market Forecast by Indication
15.4 Middle East and Africa Vaccine Sales Market Forecast by Route of Administration
15.5 Middle East and Africa Vaccine Sales Market Forecast by Type
15.6 Middle East and Africa Vaccine Sales Market Forecast by Distribution Channel
15.7 Middle East and Africa Vaccine Sales Market Forecast by Age Group
15.8 GCC Vaccine Sales Market Forecast, 2022-2032
15.8.1 GCC Vaccine Sales Industry Analysis
15.8.2 Gulf Nations Have United to Support COVAX
15.8.3 GCC Vaccine Sales Market Revenue, 2022-2032
15.8.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Vaccine Sales Market Forecast, 2022-2032
15.9 South Africa Vaccine Sales Market Forecast, 2022-2032
15.9.1 COVAX Delivering Vaccines to Africa
15.9.2 South Africa Vaccine Sales Industry Analysis
15.9.3 South Africa Vaccine Sales Market Revenue, 2022-2032
15.9.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Vaccine Sales Market Forecast, 2022-2032
15.10 Rest of Middle East and Africa Vaccine Sales Market Forecast, 2022-2032
15.10.1 Rest of Middle East and Africa Vaccine Sales Market Revenue, 2022-2032
15.10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Vaccine Sales Market Forecast, 2022-2032

16 Company Profiles
16.1 Bavarian Nordic
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Financial Analysis
16.1.3.1 Net Revenue, 2015-2020
16.1.3.2 R&D Expenses, 2015-2020
16.1.3.3 Gross Profit, 2015-2020
16.1.4 Product Benchmarking
16.1.5 Recent Developments till December 2021
16.2 Bharat Biotech
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Product Benchmarking
16.2.4 Recent Developments till December 2021
16.3 CSL Limited
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.3.1 Net Revenue, 2015-2020
16.3.3.2 R&D Expenses, 2015-2020
16.3.3.3 Gross Profit, 2015-2020
16.3.4 Product Benchmarking
16.3.5 Recent Developments till December 2021
16.4 Emergent BioSolutions Inc.
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.3.1 Net Revenue, 2015-2020
16.4.3.2 R&D Expenses, 2015-2020
16.4.3.3 Gross Profit, 2015-2020
16.4.4 Product Benchmarking
16.4.5 Recent Developments till December 2021
16.5 GlaxoSmithKline plc
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Financial Analysis
16.5.3.1 Net Revenue, 2015-2020
16.5.3.2 R&D Expenses, 2015-2020
16.5.3.3 Gross Profit, 2015-2020
16.5.4 Product Benchmarking
16.5.5 Recent Developments till December 2021
16.6 Inovio Pharmaceuticals, Inc.
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Financial Analysis
16.6.3.1 Net Revenue, 2015-2020
16.6.3.2 R&D Expenses, 2015-2020
16.6.3.3 Gross Profit, 2015-2020
16.6.4 Product Benchmarking
16.6.5 Recent Developments till December 2021
16.7 J&J
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Financial Analysis
16.7.3.1 Net Revenue, 2015-2020
16.7.3.2 R&D Expenses, 2015-2020
16.7.3.3 Gross Profit, 2015-2020
16.7.4 Product Benchmarking
16.7.5 Recent Developments till December 2021
16.8 Merck Co., Inc.
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Financial Analysis
16.8.3.1 Net Revenue, 2015-2020
16.8.3.2 R&D Expenses, 2015-2020
16.8.3.3 Gross Profit, 2015-2020
16.8.4 Product Benchmarking
16.8.5 Recent Developments till December 2021
16.9 Mitsubishi Tanabe Pharma Corporation
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Product Benchmarking
16.9.4 Recent Developments till December 2021
16.10 Moderna, Inc.
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Financial Analysis
16.10.3.1 Net Revenue, 2015-2020
16.10.3.2 R&D Expenses, 2015-2020
16.10.3.3 Gross Profit, 2015-2020
16.10.4 Product Benchmarking
16.10.5 Recent Developments till December 2021
16.11 Novavax
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Financial Analysis
16.11.3.1 Net Revenue, 2015-2020
16.11.3.2 R&D Expenses, 2015-2020
16.11.3.3 Gross Profit, 2015-2020
16.11.4 Product Benchmarking
16.11.5 Recent Developments till December 2021
16.12 Panacea Biotec Ltd.
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Product Benchmarking
16.13 Pfizer Inc.
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Financial Analysis
16.13.3.1 Net Revenue, 2015-2020
16.13.3.2 R&D Expenses, 2015-2020
16.13.3.3 Gross Profit, 2015-2020
16.13.4 Product Benchmarking
16.13.5 Recent Developments till December 2021
16.14 Sanofi
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Financial Analysis
16.14.3.1 Net Revenue, 2015-2020
16.14.3.2 R&D Expenses, 2015-2020
16.14.3.3 Gross Profit, 2015-2020
16.14.4 Product Benchmarking
16.14.5 Recent Developments till December 2021
16.15 Serum Institute of India Pvt. Ltd.
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Product Benchmarking
16.15.4 Recent Developments till December 2021
16.16 AstraZeneca PLC
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Financial Analysis
16.16.3.1 Net Revenue, 2015-2020
16.16.3.2 R&D Expenses, 2015-2020
16.16.3.3 Gross Profit, 2015-2020
16.16.4 Product Benchmarking
16.16.5 Recent Developments till December 2021
16.17 Sinopharm
16.17.1 Company Snapshot
16.17.2 Company Overview
16.17.3 Product Benchmarking
16.18 SINOVAC
16.18.1 Company Snapshot
16.18.2 Company Overview
16.18.3 Financial Analysis
16.18.3.1 Net Revenue, 2015-2020
16.18.3.2 R&D Expenses, 2015-2020
16.18.3.3 Gross Profit, 2015-2020
16.18.4 Product Benchmarking
16.18.5 Recent Developments till December 2021
16.19 Takeda Pharmaceutical Company Limited
16.19.1 Company Snapshot
16.19.2 Company Overview
16.19.3 Financial Analysis
16.19.3.1 Net Revenue, 2015-2020
16.19.3.2 R&D Expenses, 2015-2020
16.19.3.3 Gross Profit, 2015-2020
16.19.4 Product Benchmarking
16.19.5 Recent Developments till December 2021
16.20 Daiichi Sankyo Co., Ltd.
16.20.1 Company Snapshot
16.20.2 Company Overview
16.20.3 Financial Analysis
16.20.3.1 Net Revenue, 2015-2020
16.20.3.2 R&D Expenses, 2015-2020
16.20.3.3 Gross Profit, 2015-2020
16.20.4 Product Benchmarking
16.20.5 Recent Developments till December 2021

17 Conclusion and Recommendations
17.1 Concluding Remarks
17.2 Recommendations

List of Tables
Table 1 Global Vaccine Sales Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
Table 2 Global COVID-19 Vaccine Tracker by Company & Vaccine Type
Table 3 Vaccine Sales Market 2022 - 2032
Table 4 Vaccine Sales Market Forecast, 2022 - 2032: "V" Shaped Recovery
Table 5 Vaccine Sales Market Forecast, 2022 - 2032: "U" Shaped Recovery
Table 6 Vaccine Sales Market Forecast, 2022 - 2032: "W" Shaped Recovery
Table 7 Vaccine Sales Market Forecast, 2022 - 2032: "L" Shaped Recovery
Table 8 Global Vaccine Sales Market Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 9 Global Vaccine Sales Market Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global Vaccine Sales Market Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global Vaccine Sales Market Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global Vaccine Sales Market Forecast by Region, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Vaccine Types
Table 14 Global Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 15 Global Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 16 Global Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 17 Global Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 18 Global Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 19 Global Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 20 Global Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 23 Global Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 24 Global Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 25 Global Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 26 Global Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 27 Global Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 28 Global Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 29 Global Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%)
Table 30 Global Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 31 Global Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 32 Global Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 33 Global Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 34 Global Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 35 Global Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 36 Global Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 37 Global Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 38 Global Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 39 North America Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 40 North America Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 41 North America Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 42 North America Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 43 North America Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 44 North America Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 45 North America Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 46 North America Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 47 North America Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 48 North America Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 49 North America Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 50 North America Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 51 North America Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 52 North America Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 53 North America Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 54 North America Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 55 North America Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%)
Table 56 North America Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 57 North America Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 58 North America Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 59 North America Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 60 North America Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 61 North America Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 62 North America Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 63 North America Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 64 North America Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 65 U.S. Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 66 U.S. Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 67 U.S. Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 68 U.S. Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 69 U.S. Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 70 Canada Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 71 Canada Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 72 Canada Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 73 Canada Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 74 Canada Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 75 Europe Vaccine Sales Market Forecast by Country, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 76 Europe Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 77 Europe Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 78 Europe Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 79 Europe Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 80 Europe Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 81 Europe Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 82 Europe Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 83 Europe Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 84 Europe Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 85 Europe Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 86 Europe Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 87 Europe Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 88 Europe Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 89 Europe Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 90 Europe Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 91 Europe Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%)
Table 92 Europe Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 93 Europe Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 94 Europe Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 95 Europe Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 96 Europe Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 97 Europe Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 98 Europe Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 99 Europe Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 100 Europe Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 101 Germany Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 102 Germany Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 103 Germany Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 104 Germany Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 105 Germany Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 106 UK Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 107 UK Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 108 UK Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 109 UK Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 110 UK Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 111 France Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 112 France Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 113 France Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 114 France Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 115 France Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 116 Italy Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 117 Italy Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 118 Italy Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 119 Italy Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 120 Italy Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 121 Spain Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 122 Spain Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 123 Spain Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 124 Spain Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 125 Spain Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 126 Russia Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 127 Russia Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 128 Russia Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 129 Russia Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 130 Russia Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 131 Rest of Europe Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 132 Rest of Europe Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 133 Rest of Europe Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 134 Rest of Europe Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 135 Rest of Europe Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 136 Asia Pacific Vaccine Sales Market Forecast by Country, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 137 Asia Pacific Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 138 Asia Pacific Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 139 Asia Pacific Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 140 Asia Pacific Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 141 Asia Pacific Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 142 Asia Pacific Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 143 Asia Pacific Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 144 Asia Pacific Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 145 Asia Pacific Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 146 Asia Pacific Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 147 Asia Pacific Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 148 Asia Pacific Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 149 Asia Pacific Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 150 Asia Pacific Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 151 Asia Pacific Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 152 Asia Pacific Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%)
Table 153 Asia Pacific Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 154 Asia Pacific Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 155 Asia Pacific Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 156 Asia Pacific Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 157 Asia Pacific Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 158 Asia Pacific Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 159 Asia Pacific Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 160 Asia Pacific Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 161 Asia Pacific Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 162 Japan Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 163 Japan Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 164 Japan Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 165 Japan Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 166 Japan Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 167 China Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 168 China Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 169 China Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 170 China Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 171 China Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 172 India Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 173 India Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 174 India Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 175 India Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 176 India Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 177 Australia Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 178 Australia Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 179 Australia Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 180 Australia Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 181 Australia Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 182 Rest of APAC Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 183 Rest of Asia Pacific Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 184 Rest of Asia Pacific Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 185 Rest of Asia Pacific Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 186 Rest of Asia Pacific Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 187 Latin America Vaccine Sales Market Forecast by Country, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 188 Latin America Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 189 Latin America Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 190 Latin America Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 191 Latin America Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 192 Latin America Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 193 Latin America Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 194 Latin America Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 195 Latin America Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 196 Latin America Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 197 Latin America Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 198 Latin America Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 199 Latin America Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 200 Latin America Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 201 Latin America Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 202 Latin America Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 203 Latin America Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%)
Table 204 Latin America Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 205 Latin America Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 206 Latin America Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 207 Latin America Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 208 Latin America Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 209 Latin America Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 210 Latin America Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 211 Latin America Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 212 Latin America Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 213 Brazil Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 214 Brazil Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 215 Brazil Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 216 Brazil Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 217 Brazil Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 218 Mexico Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 219 Mexico Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 220 Mexico Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 221 Mexico Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 222 Mexico Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 223 Rest of LATAM Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 224 Rest of Latin America Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 225 Rest of Latin America Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 226 Rest of Latin America Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 227 Rest of Latin America Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 228 MEA Vaccine Sales Market Forecast by Country, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 229 MEA Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 230 MEA Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 231 MEA Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 232 MEA Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 233 MEA Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 234 MEA Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 235 MEA Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 236 MEA Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 237 MEA Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 238 MEA Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 239 MEA Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 240 MEA Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 241 MEA Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 242 MEA Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 243 MEA Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 244 MEA Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%)
Table 245 MEA Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 246 MEA Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 247 MEA Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 248 MEA Vaccine Sales Market Forecast by Distribution Channel , 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 249 MEA Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 250 MEA Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 251 MEA Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 252 MEA Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 253 MEA Vaccine Sales Market Forecast by Age Group, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 254 GCC Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 255 GCC Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 256 GCC Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 257 GCC Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 258 GCC Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 259 South Africa Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 260 South Africa Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 261 South Africa Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 262 South Africa Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 263 South Africa Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 264 Rest of MEA Vaccine Sales Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 265 Rest of MEA Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 266 Rest of MEA Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 267 Rest of MEA Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 268 Rest of MEA Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 269 Bavarian Nordic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 270 Bavarian Nordic: Product Benchmarking
Table 271 Bavarian Nordic: Recent Developments till December 2021
Table 272 Bharat Biotech: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 273 Bharat Biotech: Product Benchmarking
Table 274 Bharat Biotech: Recent Developments till December 2021
Table 275 CSL Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 276 CSL Limited: Product Benchmarking
Table 277 CSL Limited: Recent Developments till December 2021
Table 278 Emergent BioSolutions Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 279 Emergent BioSolutions Inc.: Product Benchmarking
Table 280 Emergent BioSolutions Inc.: Recent Developments till December 2021
Table 281 GlaxoSmithKline plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 282 GlaxoSmithKline plc: Product Benchmarking
Table 283 GlaxoSmithKline plc: Recent Developments till December 2021
Table 284 Inovio Pharmaceuticals, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 285 Inovio Pharmaceuticals, Inc.: Product Benchmarking
Table 286 Inovio Pharmaceuticals, Inc.: Recent Developments till December 2021
Table 287 J&J: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 288 J&J: Product Benchmarking
Table 289 J&J: Recent Developments till December 2021
Table 290 Merck Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 291 Merck Co., Inc.: Product Benchmarking
Table 292 Merck Co., Inc.: Recent Developments till December 2021
Table 293 Mitsubishi Tanabe Pharma Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 294 Mitsubishi Tanabe Pharma Corporation: Product Benchmarking
Table 295 Mitsubishi Tanabe Pharma Corporation: Recent Developments till December 2021
Table 296 Moderna, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 297 Moderna, Inc.: Product Benchmarking
Table 298 Moderna, Inc.: Recent Developments till December 2021
Table 299 Novavax: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 300 Novavax: Product Benchmarking
Table 301 Novavax: Recent Developments till December 2021
Table 302 Panacea Biotec Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 303 Panacea Biotec Ltd.: Product Benchmarking
Table 304 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 305 Pfizer Inc.: Product Benchmarking
Table 306 Pfizer Inc.: Recent Developments till December 2021
Table 307 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 308 Sanofi: Product Benchmarking
Table 309 Sanofi: Recent Developments till December 2021
Table 310 Serum Institute of India Pvt. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 311 Serum Institute of India Pvt. Ltd.: Product Benchmarking
Table 312 Serum Institute of India Pvt. Ltd.: Recent Developments till December 2021
Table 313 AstraZeneca PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 314 AstraZeneca PLC: Product Benchmarking
Table 315 AstraZeneca PLC: Recent Developments till December 2021
Table 316 Sinopharm: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 317 Sinopharm: Product Benchmarking
Table 318 SINOVAC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 319 SINOVAC: Product Benchmarking
Table 320 SINOVAC: Recent Developments till December 2021
Table 321 Takeda Pharmaceutical Company Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 322 Takeda Pharmaceutical Company Limited: Product Benchmarking
Table 323 Takeda Pharmaceutical Company Limited: Recent Developments till December 2021
Table 324 Daiichi Sankyo Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 325 Daiichi Sankyo Co., Ltd.: Product Benchmarking
Table 326 Daiichi Sankyo Co., Ltd.: Recent Developments till December 2021
?

List of Figures
Figure 1 Global Vaccine Sales Market: Market Segmentation
Figure 2 Top Recipients of COVID-19 R&D Funding in US$ million (As of March 2021)
Figure 3 Global Vaccine Sales Market Trends
Figure 1 Global Vaccine Sales Market: SWOT Analysis
Figure 2 PEST Analysis
Figure 3 Global Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 4 Global Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR %): “V” Shaped Recovery
Figure 5 Global Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR %): “U” Shaped Recovery
Figure 6 Global Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR %): “W” Shaped Recovery
Figure 7 Global Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR %): “L” Shaped Recovery
Figure 8 Global Vaccine Sales Market Share Forecast by Region 2022, 2027, 2032 (%)
Figure 9 Global Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 10 Global Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR %): “V” Shaped Recovery
Figure 11 Global Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR %): “U” Shaped Recovery
Figure 12 Global Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR %): “W” Shaped Recovery
Figure 13 Global Vaccine Sales Market Forecast, 2022-2032 (US$ billion, AGR %): “L” Shaped Recovery
Figure 14 Global Vaccine Sales Market Share Forecast by Indication: 2022, & 2032 (%)
Figure 15 Global Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR %)
Figure 16 Global Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR %): “V” Shaped Recovery
Figure 17 Global Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR %): “U” Shaped Recovery
Figure 18 Global Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR %): “W” Shaped Recovery
Figure 19 Global Vaccine Sales Market Forecast by Indication, 2022-2032 (US$ billion, AGR %): “L” Shaped Recovery
Figure 20 Global Vaccine Sales Market Share Forecast by Route of Administration: 2022, 2027, 2032 (%)
Figure 21 Global Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 22 Global Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %): “V” Shaped Recovery
Figure 23 Global Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %): “U” Shaped Recovery
Figure 24 Global Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %): “W” Shaped Recovery
Figure 25 Global Vaccine Sales Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %): “L” Shaped Recovery
Figure 26 Global Vaccine Sales Market Share Forecast by Type: 2022, 2027, 2032 (%)
Figure 27 Global Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR %)
Figure 28 Global Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR %): “V” Shaped Recovery
Figure 29 Global Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR %): “U” Shaped Recovery
Figure 30 Global Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR %): “W” Shaped Recovery
Figure 31 Global Vaccine Sales Market Forecast by Type, 2022-2032 (US$ billion, AGR %): “L” Shaped Recovery
Figure 32 Global Vaccine Sales Market Share Forecast by Distribution Channel: 2022, 2027, 2032 (%)
Figure 33 Global Vaccine Sales Market Forecast by Distribution Channel, 2022-2032 (US$ billion, AGR %)
Figure 34 Global Vaccine Sales Market Forecast by Distribution Channel, 2022-2032 (US$ billion, AGR %): “V” Shaped Recovery
Figure 35 Global Vaccine Sales Market Forecast by Distribution Channel, 2022-2032 (US$ billion, AGR %): “U” Shaped Recovery
Figure 36 Global Vaccine Sales Market Forecast by Distribution Channel, 2022-2032 (US$ billion, AGR %): “W” Shaped Recovery
Figure 37 Global Vaccine Sales Market Forecast by Distribution Channel, 2022-2032 (US$ billion, AGR %): “L” Shaped Recovery
Figure 38 Global Vaccine Sales Market Share Forecast by Age Group: 2022, 2027, 2032 (%)
Figure 39 Global Va